Phase 2 Respiratory Syncytial Virus (RSV) Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Respiratory Syncytial Virus (RSV)
Johns Hopkins University170 enrolled1 locationNCT07050732
Recruiting
Phase 2
Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV
Respiratory Syncytial Virus (RSV)
PENTA Foundation120 enrolled8 locationsNCT06873633